Lorvotuzumab is a humanized monoclonal antibody that specifically targets CD56 (NCAM1), a surface molecule widely expressed in various neural and muscle tissues, and certain types of cancer cells. This antibody serves as a foundational component for the development of antibody-drug conjugates (ADCs), including the synthesis of Lorvotuzumab mertansine, an ADC designed for targeted cancer therapy. Lorvotuzumab's high specificity and binding affinity make it an essential tool in research focused on the therapeutic targeting of CD56-expressing cells.
Lorvotuzumab is a humanized monoclonal antibody that specifically targets CD56 (NCAM1), a surface molecule widely expressed in various neural and muscle tissues, and certain types of cancer cells. This antibody serves as a foundational component for the development of antibody-drug conjugates (ADCs), including the synthesis of Lorvotuzumab mertansine, an ADC designed for targeted cancer therapy. Lorvotuzumab's high specificity and binding affinity make it an essential tool in research focused on the therapeutic targeting of CD56-expressing cells.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
